Back

Targeting triglycerides: is it worth it? lessons from recent trials

1 September 2024 (11:24 - 11:36)
Organised by: Logo
Add to my library
Congress Presentation Part of: Targeting lipids above and beyond statins: key new players Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Giovanna Liuzzo

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
PCSK9 inhibition: new insights
Professor L. Raber (Bern, CH)
Slides Video
Presentation thumbnail
Strategies to inhibit Lp(a)
Professor F. Kronenberg (Innsbruck, AT)
Slides Video
Presentation thumbnail
Additional cholesterol synthesis inhibition, CETP inhibitors, and cholesterol-efflux enhancer therapies
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
Targeting lipids above and beyond statins: key new players - discussion
Video

Access the full session

Session thumbnail
Targeting lipids above and beyond statins: key new players
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:24 CET
You may be interested in
thumbnail
Congress Presentation
Do triglycerides matter?
30 August 2025
thumbnail
Congress Presentation
Understanding the role of triglycerides in the assessment of residual risk
31 August 2024
thumbnail
Congress Presentation
Update on triglycerides and nutraceuticals
31 August 2025
thumbnail
Congress Presentation
We should target triglycerides to decrease cardiovascular risk: con
28 August 2023

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources